Glucagon-like peptide-1 receptor agonists as a disease-modifying therapy for knee osteoarthritis mediated by weight loss: findings from the Shanghai Osteoarthritis Cohort
Pubmed link : https://pubmed.ncbi.nlm.nih.gov/37258065/
- Forums
- ASX - By Stock
- PAR
- General OA media and info
PAR
paradigm biopharmaceuticals limited..
Add to My Watchlist
1.70%
!
43.3¢

General OA media and info, page-433
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
43.3¢ |
Change
-0.008(1.70%) |
Mkt cap ! $171.8M |
Open | High | Low | Value | Volume |
44.5¢ | 44.5¢ | 42.5¢ | $118.4K | 275.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 26779 | 43.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
43.5¢ | 8300 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 26779 | 0.430 |
6 | 89784 | 0.425 |
8 | 116842 | 0.420 |
8 | 198039 | 0.415 |
8 | 122446 | 0.410 |
Price($) | Vol. | No. |
---|---|---|
0.435 | 8300 | 4 |
0.440 | 32910 | 5 |
0.445 | 10047 | 5 |
0.450 | 43718 | 3 |
0.460 | 25378 | 3 |
Last trade - 11.47am 16/07/2025 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |
The Watchlist
CC9
CHARIOT CORPORATION LTD
Shanthar Pathmanathan, MD
Shanthar Pathmanathan
MD
Previous Video
Next Video
SPONSORED BY The Market Online